US$ 29.75
glp 1 agonist diabetes Clinical Focus on GLP-1 Agonists in Type 2 Mellitus Glucagon-like peptide-1 receptor: mechanisms and
Description
The recent studies have explored the physiological effects of GLP-1RA on body organs, establishing them as a potential therapeutic option for a wide range of diseases

Ozempic is a specific brand of GLP-1 receptor agonist used to manage type 2 diabetes and obesity

and global prevalence of type 2 diabetes and obesity, advancements in drug development, and expanding indications for weight loss and cardiovascular health
Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease study 2019

The exact brain region mediating this action is still under investigation
